OpenVSafe by OpenVAERS
Search V-safe

WZT-23426-01612

3 vaccinations 4 coded responses 35 check-ins 4 free-text entries 2 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
481 / MI
Registered
2020-12-22
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-22
    Registered in v-safe
  2. 2020-12-22
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-22
    Survey response — day 0, dose 1
    MedDRA: Unevaluable event — Feeling: Good · Headache
    Free text: I had a headache before i got the vaccine, no change
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2020-12-23
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Only the night prior, did not persist today
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2020-12-23
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  6. 2020-12-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Nausea
    Adult check-in
  7. 2020-12-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2020-12-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Nausea, Vomiting · Be unable to do your normal daily activities
    Adult check-in
  9. 2020-12-27
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  10. 2020-12-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fever · Nausea
    Adult check-in
  11. 2020-12-29
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  12. 2021-01-12
    Dose 2 — Pfizer-BioNTech
  13. 2021-01-12
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  14. 2021-01-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  15. 2021-01-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness · None
    Adult check-in
  16. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-01-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-01-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-01-19
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-01-26
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-02-02
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-09
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-02-18
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-02-23
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-04-13
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-07-13
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-10-23
    Dose 3 — Pfizer-BioNTech
  28. 2021-10-23
    Health check-in — day 0, dose 3
    Feeling: Good · None
    Adult check-in
  29. 2021-10-24
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Muscle or body aches, Nausea
    Adult check-in
  30. 2021-10-25
    Survey response — days 1–6 daily, dose 3
    MedDRA: Axillary pain, Lymphadenopathy — Feeling: Good · Site: Pain, Itching
    Free text: Lymphadenopathy right axilla, mild pain, this is the same arm as the shot
    MedDRA releases: 2024-11 · check-in free text available
  31. 2021-10-26
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Lymphadenopathy nearly gone
    MedDRA releases: 2024-11 · check-in free text available
  32. 2021-10-27
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  33. 2021-10-28
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  34. 2021-10-30
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  35. 2021-11-06
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  36. 2021-11-13
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  37. 2021-11-20
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  38. 2021-12-04
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  39. 2022-01-22
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  40. 2022-04-25
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  41. 2022-10-23
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-22Pfizer-BioNTech
22021-01-12Pfizer-BioNTech
32021-10-23Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2020-12-23 priority 2/3
2020-12-27 priority 2/3

Free text

Release 1 — day 0, dose 1

2020-12-22

Systemic reaction (other): I had a headache before i got the vaccine, no change

Release 1 — days 1–6 daily, dose 1

2020-12-23

Systemic reaction (other): Only the night prior, did not persist today

Release 10 — days 1–6 daily, dose 3

2021-10-25

Systemic reaction (other): Lymphadenopathy right axilla, mild pain, this is the same arm as the shot

2021-10-26

Systemic reaction (other): Lymphadenopathy nearly gone

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROAxillary pain · · ✓
SROCondition aggravated ○ ○ ○
SROLymphadenopathy · · ✓
SRONo adverse event ✓ ✓ ✓
SROUnevaluable event ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release